Regulation ofblood flow and mitochondrial respiration in the heart would be clarified by improved knowledge of interstitial concentrations and cellular production rates of adenosine; however, these variables cannot be measured directly. To interpret indexes that are available, a comprehensive mathematical model was developed, based on a large body of experimental data. The model describes most of the important pathways of capillary-tissue transport and cellular metabolism of adenosine in the guinea pig heart. It includes capillary flow, solute transport between tissue regions, nonlinear enzyme kinetics for adenosine kinase and adenosine deaminase, and reversible biunireactant kinetics for S-adenosylhomocysteine hydrolase in cardiomyocytes and endothelial cells, intracellular production of adenosine via AMP hydrolysis and transmethylation, and extracellular production of adenosine. A single set of parameter values for the model was obtained in the first stage of the analysis by taking certain values directly from published sources, other values were subject to specific constraints, and other values were determined by parameter optimization. The effects of flow and endothelial metabolism on the relation between interstitial and venous adenosine concentrations were determined. The relation between myocardial adenosine production rate and S-adenosylhomocysteine accumulation in the presence of excess homocysteine was estimated. In the second stage of the analysis, the model was used to investigate the mechanism of myocardial adenosine production, without changing the parameter values. Cellular adenosine production rates were estimated by fitting measurements of venous adenosine release obtained during altered energetic conditions in experiments by different investigators. The original results showed a dissociation between measurements of cytosolic AMP concentrations and venous adenosine release. It is concluded that 1) it is essential to account for the effect of flow on interstitial and venous adenosine concentrations, since decreased flow may produce effects outwardly resembling inhibition of the enzyme 5'-nucleotidase, 2) adenosine concentrations in epicardial transudate are not in equilibrium with interstitial fluid, and 3) the rate of cellular adenosine production increases monotonically with free cytosolic concentrations of AMP during a variety of alterations in energy balance of the guinea pig heart. (Circulabton Research 1992;71:590-604) KEY WoRDs * myocardium * homocysteine energetics * kinetics t has been hypothesized that under certain conditions coronary blood flow, sinus node depolarization, atrioventricular node transmission, the inotropic response due to sympathetic stimulation, the rate of glycolysis, and the generation of oxygenderived free radicals by activated neutrophils are regulated via the actions of interstitial adenosine on adenosine receptors located on effector cell membranes (for overviews see References 1-3). Experimental tests of these hypotheses rely heavily on assessments of interstitial adenosine concentrations or Received January 28, 1992; accepted April 30, 1992. transmethylation * endothelial cell * purinesmyocardial adenosine production rates. However, neither quantity can be directly measured because of problems of compartmentalization4 and the effects of capillary transport and cellular metabolism. The goal of the present study was to develop a comprehensive mathematical model to estimate interstitial adenosine concentrations and cytosolic adenosine production rates in the guinea pig heart. Previous mathematical models of adenosine in the heart have focused on specific aspects of transport and metabolism. Kohn and Garfinkel5 developed a nonlinear model for the ischemic rat heart, which described vectorial production of adenosine in the interstitial space from membrane-associated AMP produced by phosphodiesterase and cellular metabolism by adenosine kinase and adenosine deaminase. The model did not describe the S-adenosylhomocysteine (SAH) pathway, intracellular production of adenosine, or endothelial cells and accounted for flow via first-order exchange between the interstitial and vascular compartments. 
t has been hypothesized that under certain conditions coronary blood flow, sinus node depolarization, atrioventricular node transmission, the inotropic response due to sympathetic stimulation, the rate of glycolysis, and the generation of oxygenderived free radicals by activated neutrophils are regulated via the actions of interstitial adenosine on adenosine receptors located on effector cell membranes (for overviews see . Experimental tests of these hypotheses rely heavily on assessments of interstitial adenosine concentrations or 
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Newby6 developed a nonlinear model to analyze the effects of blockade of membrane adenosine transport by dipyridamole. The model described two cell types: a production site and a trap. The model included adenosine deaminase and adenosine kinase but not SAH hydrolase and did not describe the endothelial metabolic barrier between the vascular and interstitial spaces.
Wangler et a17 developed a multiple-region (capillary, endothelial cell, interstitial fluid, and parenchymal cell) axially distributed adenosine model to analyze results of multiple-indicator dilution experiments. The model included linear transport, metabolism, and regional flow heterogeneity but did not describe intracellular adenosine formation or separate enzymatic pathways for adenosine. The present model is an extension of the Wangler model, since flow and transport are accounted for in much the same way. The major differences are that the present model accounts for individual enzymatic pathways for adenosine using nonlinear reversible kinetics, intracellular adenosine production in both endothelial cells and cardiomyocytes, and an additional tissue region for epicardial transudates.
The two-stage design of the present study was as follows. In the first stage, the structure of the model and a single set of parameter values were determined by analyzing a large body of data describing adenosine transport and metabolism in the heart. Because no single set of observations contains sufficient information to describe all the important pathways, analyzing many different measurements was essential to develop a comprehensive model. The experimental observations included 1) results from multiple-indicator dilution studies,7-9 2) morphometric measurements,10-'2 3) in vitro measurements of enzyme kinetics,'3-17 4) results from cultured cells, '8 5) coronary venous adenosine release rates and myocardial SAH content under normoxic and hypoxic conditions, 14 6) myocardial SAH content in the presence of a blocker of the enzyme SAH hydrolase,15 7) capillary endothelial cell trapping of tracer adenosine, supplied via the arterial inflow, 19 8) epicardial transudate concentrations of adenosine,20,21 and 9) the endothelial cell contribution to total venous release of adenosine. 22 In the second stage of analysis, the model parameter values were left unchanged, and the model was used to clarify an inconsistency observed by different investigators2023-25 on the mechanism of cellular production of adenosine. In these experiments, free cytosolic AMP concentrations were determined under conditions of altered myocardial energetics. The venous release rate of adenosine was measured as an index of myocardial adenosine production. During hypoxic perfusion, studied by He et 23 To explain this finding, He et al suggested that cytosolic 5'-nucleotidase, the enzyme producing adenosine from AMP, was subject to allosteric inhibition during ischemia. However, the use of venous adenosine release as an index of cellular production did not account for the effects of flow or capillary endothelial cell metabolism of adenosine. 19 Therefore, the present model was used to estimate the rate of cellular production Solute exchange between regions is described bypermeabilitysurface area products. ISF, interstitial fluid; Ado, adenosine;
Hcy, homocysteine; SAM, S-adenosylmethionine.
of adenosine during altered energetics by analyzing the measurements of venous release. The analysis explained the dissociation between venous release and AMP concentrations and revealed that, in all the data sets, myocardial adenosine production was directly related to cytosolic AMP concentrations over the entire range of myocardial energetics.
Materials and Methods Structure of the Model
Overview ofmodel. The model equations are based on the principle of the conservation of mass and steady plug flow in the capillary and the absence of radial concentration gradients within the model regions. The model, one capillary pathway of which is shown in Figure 1 
The final term in Equation 7 describes product inhibition of transmethylation by SAH. 16 For tracer adenosine, homocysteine, and SAH, the transport and enzyme fluxes are governed by the concentrations of the nontracer mother substance and are equal to the specific activity times the flux of the mother substance.
The unidirectional reactions of the SAH hydrolase enzyme are described using a biunireactant kinetic scheme, assuming random order and equilibrium binding of reactants and products28:
vssyn [ (12) Using the Km values listed in Table 1 Table 3 . Table 3 includes estimates of interstitial concentrations. Parameter values were identical to those in Table 1 . Inflow adenosine concentrations were set to equal those used in the experiments. The authors noted that only at an inflow concentration of 300 nM was the venous concentration lower than either the inflow or the transudate concentration. This qualitative behavior was also described by the model. These measurements provided constraints on the parameters describing the endothelial barrier for adenosine and parenchymal cell PS for adenosine (PSpc).
9: CONTRIBUTION OF ENDOTHELIAL CELLS TO VENOUS RELEASE OF ADENOSINE. Kroll et a122 estimated that capillary endothelial cells contribute 14% of the total venous release of adenosine under control conditions. Modeling steady-state control conditions using the parameters listed in Table 1 indicated that the endothelial cell contribution was 15%. This measurement provided a constraint on the endothelial cell production rate of adenosine. Figure 2 . Symbols show measurements of SAH during perfusion with medium containing excess L-homocysteine thiolactone beginning at time=0, under normoxic (solid symbols) and hypoxic (open symbols) conditions. Model solutions are shown by the continuous curves. The only differences between the two model solutions were the cellular adenosine production rates (20-fold higher for hypoxia solution), the flow rates, and the inflow homocysteine concentrations, which were set to measured values. The identical model solutions also fit the measured venous release rates of adenosine shown in Table 2 .
Relation between venous and interstitial adenosine concentrations. EFFECT OF CELLULAR ADENOSINE PRODUC-TION. The model was used to estimate steady-state venous and interstitial adenosine concentrations when cellular adenosine production and flow rates were altered and the arterial concentration was zero. In Figure  3A , isoflow lines (along which production increases) slope upward linearly from the origin. Isoproduction lines (along which flow decreases) curve more steeply upward from the x axis. Increasing flow at a constant production rate decreases venous concentrations more than interstitial concentrations; i.e., washout of interstitial adenosine is minor. The figure may be used as a nomogram to estimate interstitial adenosine concentrations by drawing a vertical line from the intersection of a measured venous concentration (y axis) and the corresponding isoflow line. The model estimate of the corresponding myocardial adenosine production rate may be interpolated from the neighboring isoproduction lines. (Figure 3 (2) where S' and FO denote adenosine production (1.6 nmolb g-' min -) and coronary flow (8 mlb g`. min-) at the highest flow, S' and F, are production and flow as flow was reduced, and a is a coefficient determining the steepness of the function. For the steepest function (a=2.5), adenosine production increased 244-fold over control levels at the lowest flow. Parenchymal and endothelial cell adenosine production rates were maintained in the ratio 20 
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To describe the relation between flow and adenosine production in a heart more realistically, a series of curves was used to describe increasing cellular adenosine production rates as flow was lowered (Figure 4 , inset). These curves were used to produce the other three solutions in Figure 4 to show the qualitative effect of increasing adenosine production as flow was lowered. Only for the solution in which adenosine production was increased most steeply, 244-fold at the lowest flow rate (dotted curve), did venous release rate increase continuously. Results in Figure 4 show that venous release of adenosine may decrease, even though cellular production increases.
The reason for the marked effect of flow rate on adenosine release is clarified by observing the concentration gradients along the length of the capillary (Figure 5) . At a flow rate of 16 ml* g`. min' (top panel), the endothelial cell concentration was higher than that in the capillary along the entire length of the capillary because of endothelial cell production of adenosine. The arrows indicate the direction of the concentration gradient for adenosine diffusion. The endothelial cell was a source for adenosine, and the capillary concentration increased continuously from inflow (at the left) to outflow, without reaching a stable level. At a lower flow rate of 4 ml * g. minm '(middle panel), endothelial cells were a source at the inflow end of the capillary and a sink at the outflow. The capillary concentration still did not reach a stable level. At the lowest flow rate of 0.1 ml * g`1 min' (bottom panel), the endothelial cell was a sink along most of the length of the capillary. The capillary concentration rose to a high stable level near the inflow. The source for adenosine was cardiomyocyte and extracellular production. At a flow rate of 2 ml * g`1 min' (not shown), the outflow concentration was nearly the same, but it was only reached at the end of the capillary. Calculated venous release of adenosine was 20-fold higher at a flow rate of 2 ml g-. min' compared with 0.1 ml* g`min', although adenosine production rate was identical. It should be noted that adenosine production rates were unchanged in the three panels of Figure 5 .
Flow heterogeneity. To account for the normal fivefold range in regional flow, the model included 10 parallel capillary tissue exchange units, identical except for their flow, an approach used by Wangler et al. 7 Adenosine production was assumed to be equal in all flow pathways. The effect of flow heterogeneity was to decrease total venous release by approximately 5% compared with conditions of uniform flow distribution. The effect of heterogeneity was due to reduced venous release of adenosine in low-flow pathways. Flow heterogeneity had a negligible effect on SAH accumulation.
Compartmental model. Solutions of the compartmental and distributed models were compared for cytosolic adenosine concentration and SAH accumulation in the presence of exogenous homocysteine, using identical parameter values for the cardiomyocyte region and modeling the vascular concentration of homocysteine as a step function. Solutions of the compartmental model, which does not describe flow, were within approximately 1% of solutions of the distributed model for flow rates above 1 ml g g. min-1. However, at a flow rate of 0.1 ml * g`1 * min-1 SAH accumulation was decreased by 10% in the distributed model and by 60% at a flow rate Table 1 . Arrows indicate the direction of the diffusion gradient between capillary and endothelial cells. At high flow rate (top panel), endothelial cells function as a source for adenosine, whereas at a low flow rate (bottom panel), endothelial cells function as a sink for adenosine. Between flow rates of 2 and 0.1 ml-g1. min-', nearly identical capillary outflow concentrations are reached but at different points along the capillary. As flow is increased in this range, the steady-state concentration is reached nearer to the outflow end of the capillary. of 0.01 ml * g`1 min-l. The decreases, not accounted for by the compartmental model, were due to effects of flow on homocysteine availability; adenosine production was not changed. Because of limitations in the compartmental model, it is inappropriate for modeling conditions where arteriovenous concentration gradients or endothelial cell metabolism are important.
Parameter sensitivity analysis. The relative importance of model parameters was determined by incrementing each parameter in turn by 10%. All parameters causing more than a 5% change in the solutions are listed in Figure 6A . In the studies using underperfusion to alter myocardial energetics, adenosine release was decreased at the highest AMP concentrations (corresponding to the lowest flow rates). However, when hypoxia and substrate reductions were used to alter energetics, adenosine release increased continuously with AMP concentration ( Figure 6A ).
Model estimates of cellular adenosine production rates, obtained by fitting the venous release data in Figure 6A , increased monotonically with AMP concentrations under all conditions ( Figure 6B ). During ischemia, myocardial adenosine production increased at the same time venous release decreased. The AMP concentrations in Figure 6 were taken directly from the original sources and are identical in both panels. The The parameter sensitivity analysis identified the most important parameters in the model. These included region volumes, kinetic parameters for adenosine kinase and SAH hydrolase, and adenosine production rates. Volumes and adenosine kinase parameters were rather well constrained by morphometric studies and in vitro enzyme assays. The parameters to which the most interest is attached, adenosine production rates, are among the most influential in the model. High sensitivity is essential if they are to be identified by fitting experimental measurements. Because adenosine production in both parenchymal cells and the interstitial region influenced venous concentrations, it may not be possible to distinguish between them on the basis of venous measurements alone. They may be distinguished by additional measurements of SAH accumulation in the presence of excess homocysteine, which is more sensitive to cytosolic adenosine than interstitial adenosine. A test was made of model sensitivity to the possibility that adenosine deaminase is absent in cardiomyocytes by setting Vd,=0. The largest effect was a 17%
increase in cytosolic adenosine concentration in the modeling of hypoxia.
Strengths and Weaknesses of the Model
To assess the role of adenosine as a physiological regulator and energetic marker in the heart, it is of paramount importance to estimate interstitial concentrations of adenosine and myocardial production rates. Because these variables cannot be directly measured, venous concentrations have usually been used as an index. The present model makes it possible to overcome serious weaknesses in the index by accounting for the effects of capillary transport and cellular metabolism of adenosine in a comprehensive and physically realistic manner. A major advantage of the present model is that it is based on a large number of the key experimental observations on adenosine in the heart. The ability of the model to resolve the inconsistency regarding the mechanism of myocardial adenosine production shown in Figure 6 demonstrates the utility of model analysis of adenosine measurements. An additional strength of the model is that it makes it possible to assess in vivo enzyme kinetic behavior. The true power of this approach requires that the design of experiments be developed with the aid of the model, to optimize the sensitivity of the measurements.
The model involves a number of limitations. 1) The model does not describe extracellular adenosine deaminase, the regulation of extracellular production of adenosine, or adenosine uptake and metabolism in the transudate region. Although these processes must occur, their role under normal conditions may be minor. To extend the model to include these processes, detailed measurements of extracellular production and metabolism of adenosine will be necessary.
2) The parenchymal cell Vma, for adenosine kinase is not welldefined experimentally. However, the Vm,, and cellular adenosine production rate are the key determinants of steady-state cytosolic concentration of adenosine. Therefore, the production/Vm, ratio is constrained by the measurements of SAH accumulation in the presence of excess homocysteine. There is less uncertainty in the above ratio than in the absolute value of myocardial adenosine production. 3) Another limitation is the problem of assigning specific values to the kinetic parameters for SAH hydrolase. The best fits to all the experimental observations in the present study were obtained with Km values of 2 ,uM for adenosine, 150 ,uM for homocysteine, and 3.75 bLM for SAH, whereas reported values for SAH hydrolase from guinea pig heart were 1.3 ,uM for adenosine,15 260 ,M for homocysteine,13 and 2.9 gM for SAH. 13 The model solutions for SAH content in the absence and presence of excess homocysteine were decreased by 21% and 10%, respectively, if the reported parameter values were used directly. If, in addition, the Vmax for the enzyme in the hydrolytic direction was adjusted to conform to the constraint imposed by the Haldane equation, then the solutions were increased by 35% and 1%, respectively. 4) Region volumes were taken from studies of normal hearts, which may not be appropriate for buffer-perfused hearts, since such hearts may exhibit considerable edema. The sensitivity analysis indicated that increasing the interstitial volume by 10% did not change any model solutions by more than 0.1%. However, if the parenchymal cell volume was reduced by 0.2 ml/g, to make up for a possible 0.2 ml/g increase in the interstitial volume, then the estimate of steady-state tissue SAH content in the absence of homocysteine in the inflow would be decreased by approximately 30%. The estimate of SAH accumulation in the presence of excess homocysteine would be decreased by 17%, and the estimates of adenosine concentrations would be changed by less than 0.01%. 5) Another limitation is that the model does not describe the effects of high-energy phosphate compounds on cytosolic 5'-nucleotidase, substrate inhibition of adenosine kinase by adenosine, or effects of adenine and adenine nucleotides on SAH hydrolase. The concentration ranges over which these effects are expected generally lie outside the physiological range. 6) The model does not explicitly describe inosine or AMP. 7) Finally, because the model was based on measurements obtained in guinea pig hearts, if it is applied to hearts of other species, inaccuracies are possible.
In summary, the present study provides comprehensive descriptions of the expected effects of the major pathways of transport and metabolism of adenosine in the heart. Improved estimates of interstitial adenosine concentrations and myocardial adenosine production rates were determined by accounting for the effects of flow and endothelial metabolism. The results are presented in the form of a nomogram to estimate these variables graphically. It is concluded that, although epicardial transudate and interstitial adenosine concentrations change in parallel, they are not in equilibrium, and localized adenosine production makes transudate measurements insensitive for physiological changes in interstitial adenosine. It is also concluded that cellular adenosine production is directly related to free cytosolic concentrations of AMP. Therefore, the SAH technique may provide spatially resolved information on myocardial energetics.
